The three-year-old Oakland company is working on two clinical trials for its drug-device combo aimed at setting off a chain of events to destroy brain cancer.
The three-year-old Oakland company is working on two clinical trials for its drug-device combo aimed at setting off a chain of events to destroy brain cancer.
